Biopolym. Cell. 2007; 23(6):483-488.
Adhesive proteins in inflammation process
1Zhernossekov D. D.
  1. Palladin Institute of Biochemistry, NAS of Ukraine
    9, Leontovycha Str., Kyiv, Ukraine, 01601


The inflammation process is accompanied by the expression of different adhesive molecules on the surface of both endothelium and blood cells. The adhesion proteins of immunoglobulin, selectin, and integrin family are involved at the certain stages of inflammation response. To cure chronic inflammation processes the selective influence on the molecular mechanism of adhesive interaction of leukocytes is necessary. In the present paper the search for anti-inflammatory anti-adhesive preparations on the basis of structural features of adhesive molecules is discussed.
Keywords: selectins, integrins, Ig-CAM, inflammation


[1] Simon SI, Green CE. Molecular mechanics and dynamics of leukocyte recruitment during inflammation. Annu Rev Biomed Eng. 2005;7:151-85.
[2] Kansas GS. Selectins and their ligands: current concepts and controversies. Blood. 1996;88(9):3259-87.
[3] Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J. 1994;8(8):504-12.
[4] Rodgers SD, Camphausen RT, Hammer DA. Sialyl Lewis(x)-mediated, PSGL-1-independent rolling adhesion on P-selectin. Biophys J. 2000;79(2):694-706.
[5] Strukova SM. Role of platelets and serine proteinases in coupling of blood coagulation and inflammation. Biochemistry (Mosc). 2004;69(10):1067-81.
[6] Volkov GL, Platonova TN, Savchuk AN, Gornitskaya OV, Chernyshenko TM, Krasnobrizhaya EN. Modern views on the hemostatic system. Kiev.: Naukova Dumka, 2005. 296 p.
[7] Brenner B, Kadel S, Birle A, Linderkamp O. L-selectin tyrosine phosphorylates cbl and induces association of tyrosine-phosphorylated cbl with crkl and grb2. Biochem Biophys Res Commun. 2001;282(1):41-7.
[8] Green CE, Pearson DN, Christensen NB, Simon SI. Topographic requirements and dynamics of signaling via L-selectin on neutrophils. Am J Physiol Cell Physiol. 2003;284(3):C705-17.
[9] Waddell TK, Fialkow L, Chan CK, Kishimoto TK, Downey GP. Signaling functions of L-selectin. Enhancement of tyrosine phosphorylation and activation of MAP kinase. J Biol Chem. 1995;270(25):15403-11.
[10] Schmid-Sch?nbein GW. Analysis of inflammation. Annu Rev Biomed Eng. 2006;8:93-131.
[11] Hilden TJ, Nurmi SM, Fagerholm SC, Gahmberg CG. Interfering with leukocyte integrin activation--a novel concept in the development of anti-inflammatory drugs. Ann Med. 2006;38(7):503-11.
[12] Lum AF, Green CE, Lee GR, Staunton DE, Simon SI. Dynamic regulation of LFA-1 activation and neutrophil arrest on intercellular adhesion molecule 1 (ICAM-1) in shear flow. J Biol Chem. 2002;277(23):20660-70.
[13] Mousa SA. Methods in molecular medicine. Anticoagulants, antiplatelets and thrombolytics. New York: Humana press, 2004. 320 p.
[14] Meyer A, Auernheimer J, Modlinger A, Kessler H. Targeting RGD recognizing integrins: drug development, biomaterial research, tumor imaging and targeting. Curr Pharm Des. 2006;12(22):2723-47.
[15] Chen CC. Signal transduction pathways of inflammatory gene expressions and therapeutic implications. Curr Pharm Des. 2006;12(27):3497-508.
[16] de Fougerolles AR, Qin X, Springer TA. Characterization of the function of intercellular adhesion molecule (ICAM)-3 and comparison with ICAM-1 and ICAM-2 in immune responses. J Exp Med. 1994;179(2):619-29.
[17] Kim M, Carman CV, Yang W, Salas A, Springer TA. The primacy of affinity over clustering in regulation of adhesiveness of the integrin {alpha}L{beta}2. J Cell Biol. 2004;167(6):1241-53.
[18] Shaw SK, Ma S, Kim MB, Rao RM, Hartman CU, Froio RM, Yang L, Jones T, Liu Y, Nusrat A, Parkos CA, Luscinskas FW. Coordinated redistribution of leukocyte LFA-1 and endothelial cell ICAM-1 accompany neutrophil transmigration. J Exp Med. 2004;200(12):1571-80.
[19] Newman PJ, Newman DK. Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol. 2003;23(6):953-64.
[20] Simmons DL. What makes a good anti-inflammatory drug target? Drug Discov Today. 2006;11(5-6):210-9.
[21] Humby F, Manzo A, Pitzalis C. Chemokines in arthritis: key molecules in pathogenesis and potential therapeutic targets. Fut Rheumatol. 2006;1(1):53–65.
[22] Sims MJ, Hassal DG, Brett S, Rowan W, Lockyer MJ, Angel A, Lewis AP, Hale G, Waldmann H, Crowe JS. A humanized CD18 antibody can block function without cell destruction. J Immunol. 1993;151(4):2296-308.
[23] Chavakis T, Athanasopoulos A, Rhee JS, Orlova V, Schmidt-W?ll T, Bierhaus A, May AE, Celik I, Nawroth PP, Preissner KT. Angiostatin is a novel anti-inflammatory factor by inhibiting leukocyte recruitment. Blood. 2005;105(3):1036-43.
[24] Fischer MB, Roeckl C, Parizek P, Schwarz HP, Aguzzi A. Binding of disease-associated prion protein to plasminogen. Nature. 2000;408(6811):479-83.